Jonathon Nevett 和 Karen Thiel 加入预防癌症基金会董事会

2023 年 12 月 12 日

F或立即释放

凯拉·梅斯特
703-836-1746
kyra.meister@preventcancer.org

弗吉尼亚州亚历山大市 – 预防癌症基金会^® announces the election of Jonathon Nevett and Karen Thiel to the Foundation’s board of directors. Their terms will begin on January 1, 2024. The Prevent Cancer Foundation is proud to welcome these accomplished individuals into their new roles.

乔纳森·内维特 is the president and CEO of Public Interest Registry (PIR). A veteran of the domain name industry, Mr. Nevett co-founded Donuts Inc. in 2010 and has helped to raise in excess of $150 million to form a registry of over 240 internet domain extensions. Prior to this work, Mr. Nevett served as senior vice president at Network Solutions, where he was responsible for policy, government affairs, registry relations and the corporate ethics office.

Mr. Nevett is also the co-founder of the Domain Name Association, an industry trade association, and participated in various leadership roles at the Internet Corporation for Assigned Names and Numbers (ICANN). He has served on numerous boards, including as chair of the board of NameJet and Central Registry Solutions, two joint ventures in the domain name industry, and as vice chair of the board of the Green Acres School. During the Obama Administration, Mr. Nevett was appointed to the Online Safety and Technology Working Group to help protect children on the internet.

Mr. Nevett is a cancer survivor and shared what he learned about early detection in a recent blog post for PIR.

Karen Thiel previously served as senior counsel at the Kaiser Foundation Health Plan, where she was responsible for providing legal advice to Kaiser’s senior leadership and Medicaid programs. While a partner in the Health Policy practice at Patton Boggs LLP and then as senior counsel in the Public Policy Department at Akin Gump, Ms. Thiel provided pro bono work for the Smashing Walnuts Foundation to secure multiple years of funding for the National Institutes of Health. Additionally, she provided support to the National Institutes of Health’s Biospecimen-Related Research Program on ethical, legal and policy practices for biospecimen-related research, presented at conferences—including the National Cancer Institute’s Biospecimen Best Practices Forum—and co-authored an article on these issues that was published in Cancer Epidemiology Biomarkers & Prevention.

Ms. Thiel also worked in the California State Senate, where she worked with then-State Senator John Garamendi to secure funding for a Tobacco-Related Disease Research Program that supplied funding for important research in cancer prevention and detection by researchers in California’s public and private university system.

Ms. Thiel is a breast cancer survivor.

“We’re thrilled to have Jon and Karen’s expertise as they join our dynamic board and staff to help us achieve better outcomes for all,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “In addition to their leadership qualifications from two diverse industries, their personal connections to our work enable them to bring a unique set of perspectives that will help us empower more people to stay ahead of cancer through prevention and early detection.”

###

关于预防癌症基金会^®

预防癌症基金会^® 是唯一的美国-基于非盈利机构独自投入的到癌症预防和早期检测. 通过研究、教育、外展和倡导, 我们已经帮助无数人避免癌症诊断或及早发现癌症并得到成功治疗。我们受到一个可以预防癌症的世界的愿景，可检测并且可击败对全部.

基金会正努力应对到 2035 年减少 40% 癌症死亡人数的挑战。为了实现这一目标，我们是承诺投资 $2000 万美元用于创新技术，以尽早发现癌症并推进多-癌症筛查，$1000万美元用于扩大癌症筛查和疫苗接种覆盖面医学上服务不足的社区，并投入 $10 万美元用于教育公众了解筛查和疫苗接种选择。

如需了解更多信息，请访问 www.preventcancer.org.